13F reference period
Q2 2026
Security Snapshot
agilon health, inc. - Common stock, $0.01 par value (AGL) Institutional Ownership
CUSIP: 00857U206
13F Institutional Holders and Ownership History from Q4 2025 to Q3 2026
Institutions Reporting
177
Shares (Excl. Options)
16.07M
Full value: 16,071,327 · shares · 30 Jun 2026Price
$107.18
The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended. Newer periods in the history table contain incoming reports and may be incomplete.
Save this security page for your next review
Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common stock, $0.01 par value
- Symbol
- AGL on NYSE
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 16,071,327
- Total 13F value
- $1,723,484,007
- Portfolio coverage rank
- 0%
- Share change
- +1,060,504
- Value change
- +$122,540,862
- Number of holders
- 177
- Shares outstanding
- 16,687,735
- SEC-reported price per share
- $79.59
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source
Key facts
- AGL - agilon health, inc. - Common stock, $0.01 par value is tracked under CUSIP 00857U206.
- 177 institutions reported positions in Q2 2026.
- 2 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 90 to 177 between Q1 2026 and Q2 2026.
- SEC-reported value moved from to
$119.06M
Full value: $119,061,205 · USD · 31 Mar 2026.$1.72B
Full value: $1,723,484,007 · USD · 30 Jun 2026
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 177 institutions filings for Q2 2026.
Security key
00857U206
13F reference period
Q2 2026
13F holders
177
13D/G owners
2
CIK / CUSIP context first
Open Q2 2026 holders
AGL full holder history
agilon health, inc. SEC filings
agilon health, inc. company facts
agilon health, inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 00857U206:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
2
Security
AGL
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| AQR CAPITAL MANAGEMENT LLC | 4.2% | $74,226,544 | 692,541 | AQR Capital Management, LLC | 30 Jun 2026 | |||
| GOLDMAN SACHS GROUP INC | 3.9% | $69,862,667 | 651,826 | THE GOLDMAN SACHS GROUP, INC. | 30 Jun 2026 |
As of 30 Jun 2026,
177
institutional investors reported holding
shares of
agilon health, inc. - Common stock, $0.01 par value (AGL).
This represents
96%
of the company’s total
outstanding shares.
16.07M
Full value: 16,071,327 · shares · 30 Jun 202616.69M
Full value: 16,687,735 · shares · Stored outstanding share count13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
87%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Clayton, Dubilier & Rice, LLC | 24% | 4,000,000 | 0% | 48% | $428,720,000 |
| MORGAN STANLEY | 12% | 2,011,196 | -4.2% | 0.01% | $215,560,086 |
| North Peak Capital Management, LLC | 8.9% | 1,485,066 | -3.9% | 18% | $159,169,374 |
| BlackRock, Inc. | 6.9% | 1,146,520 | +31% | 0% | $122,884,014 |
| AQR CAPITAL MANAGEMENT LLC | 4.1% | 692,541 | -29% | 0.03% | $74,226,574 |
| GOLDMAN SACHS GROUP INC | 4.1% | 686,792 | -35% | 0.01% | $73,610,338 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.1% | 525,328 | -2.5% | 0% | $56,304,655 |
| MARSHALL WACE, LLP | 2.8% | 468,293 | 0.04% | $50,191,644 | |
| Durable Capital Partners LP | 2.6% | 440,642 | 0.46% | $47,228,010 | |
| D. E. Shaw & Co., Inc. | 2.3% | 390,149 | -47% | 0.03% | $41,816,170 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2.1% | 348,960 | -4.3% | 0% | $37,401,533 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.9% | 314,165 | +18% | 0% | $33,680,139 |
| STATE STREET CORP | 1.7% | 280,126 | +10% | 0% | $30,023,905 |
| JANE STREET GROUP, LLC | 1.6% | 273,393 | +1709% | 0.02% | $29,302,262 |
| Rock Springs Capital Management LP | 1.6% | 262,600 | +1% | 1.4% | $28,145,468 |
| Nuveen, LLC | 1.4% | 229,071 | +616% | 0.01% | $24,551,831 |
| RENAISSANCE TECHNOLOGIES LLC | 0.91% | 152,214 | +2.1% | 0.02% | $16,314,297 |
| Invesco Ltd. | 0.8% | 133,144 | +228% | 0% | $14,270,373 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 0.77% | 128,328 | +16% | 0% | $13,754,195 |
| TWO SIGMA INVESTMENTS, LP | 0.75% | 125,713 | +27% | 0.01% | $13,473,919 |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 0.65% | 108,160 | 0.02% | $12,422,176 | |
| NORTHERN TRUST CORP | 0.62% | 103,432 | +7.6% | 0% | $11,085,841 |
| VANGUARD FIDUCIARY TRUST CO | 0.53% | 88,305 | +3.2% | 0% | $9,464,530 |
| BANK OF AMERICA CORP /DE/ | 0.49% | 81,626 | 0% | $8,748,674 | |
| ACADIAN ASSET MANAGEMENT LLC | 0.48% | 79,423 | +110% | 0.01% | $8,505,000 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
4
Headline period
Q2 2026
Rows shown
1-4 of 4